Flora Growth (FLGC) Stock Price, News & Analysis

Flora Growth Corp. (NASDAQ: FLGC) is a corporation organized under the laws of the Province of Ontario that has announced plans to rebrand as ZeroStack. According to recent company disclosures, Flora describes itself as the first and largest decentralized AI treasury company. Its business model focuses on investing in the future of AI infrastructure through strategic ownership of $0G, the native cryptocurrency of the distributed AI infrastructure project known as 0G, and on operating as a global pharmaceutical distributor through its wholly owned subsidiary Phatebo GmbH.

Business Focus and Strategy

Company communications state that Flora, which is set to operate under the ZeroStack name, is the first public company to offer exposure to Decentralized AI by accumulating and holding $0G tokens as a primary reserve asset. The company has entered into a series of private placements and financing transactions involving $0G tokens, Solana and other digital assets, with the stated intention of building what it calls a publicly listed 0G treasury. In these transactions, Flora has issued common shares, pre-funded warrants, common share purchase warrants and convertible notes, and has received both cash and digital assets that it intends to deploy into its digital asset treasury strategy linked to $0G.

In addition to its digital asset treasury activities, Flora describes itself as a global pharmaceutical distributor through Phatebo GmbH. Company disclosures indicate that Flora is a distributor of pharmaceutical products in the European Union and a holder of a medical cannabis licence in Germany. The company has discussed a parallel import business in Germany intended to provide a range of pharmaceuticals at competitive prices while complying with European Union regulatory requirements.

Decentralized AI and 0G Exposure

Flora’s public statements emphasize its role in providing equity-based exposure to the 0G ecosystem. The company has stated that 0G is an AI infrastructure project that has created an open and decentralized AI network fueled by the $0G token. According to Flora’s descriptions, the 0G network is characterized as an AI-first blockchain designed to support large-scale and cost-efficient AI development and distributed AI workloads. Flora’s treasury strategy involves acquiring and holding $0G tokens, with the company indicating that newly purchased tokens are expected to be held long term and staked to generate native yield.

To support the custody of its $0G holdings, Flora has appointed BitGo Trust Company, Inc. as custodian for its $0G treasury. Company disclosures describe BitGo as a digital asset infrastructure firm that provides custody and related services from regulated cold storage. Flora has presented this appointment as part of its focus on transparency, security, and working with regulated and licensed partners in connection with its digital asset holdings.

Capital Markets Activity and Listing

Flora Growth Corp. is listed on the Nasdaq Capital Market under the symbol FLGC. The company has reported that it previously received a notice from Nasdaq regarding non-compliance with the minimum bid price requirement and that it later regained compliance with this requirement after its common shares maintained a closing bid price above the specified threshold for the required period. To address its share price and capital structure, Flora’s shareholders approved a share consolidation, and the company subsequently effected a 1-for-39 share consolidation of its issued and outstanding common shares by filing Articles of Amendment in Ontario. Following this consolidation, the common shares continued to trade on the Nasdaq Capital Market under the FLGC ticker.

Beyond the share consolidation, Flora has entered into an at-the-market sales agreement with a broker-dealer to sell common shares from time to time under a Form S-3 registration statement. It has also executed multiple private placement transactions involving common shares, pre-funded warrants, common share purchase warrants and convertible notes, including arrangements with DeFi Development Corp. and Zero Gravity Labs Inc. The company has stated that the net proceeds and tokens received from these transactions are intended to further its digital asset treasury strategy linked to $0G and to support general corporate and working capital purposes.

Corporate Governance and Shareholder Meetings

Flora holds shareholder meetings to seek approval for key corporate actions. At its 2025 Annual and Special Meeting of Shareholders, the company’s shareholders voted on the election of directors, the appointment of auditors, amendments to the 2022 Incentive Compensation Plan, a share consolidation authority, and the repricing and amendment of vesting terms for certain stock appreciation rights. Subsequently, at a Special Meeting of Shareholders held on December 19, 2025, shareholders considered and approved proposals including a name change to ZeroStack Corp., the creation of a new class of preferred shares, amendments to the 2022 Incentive Compensation Plan, the grant of stock options to senior executives, approvals related to private placement issuances, authority for a potential forward share split, and the ability to adjourn or postpone the meeting if needed.

The company has also reported changes in board composition and committee structure. For example, Flora disclosed the passing of an independent director who had served on its audit, compensation, and nominating and corporate governance committees, and noted that this event temporarily affected its compliance with certain Nasdaq corporate governance requirements related to independent directors and audit committee composition. The company has indicated that it is evaluating options to regain compliance within the applicable cure period.

Digital Asset and Crypto-Related Activities

In addition to its focus on $0G, Flora has disclosed that it established a strategic long-term crypto portfolio anchored by holdings in Ethereum, Solana, Sui and Ripple. The company has characterized this move as an investment into the cryptocurrency and blockchain sector and has described its objective as building a portfolio of disruptive crypto assets and technologies. Flora has linked this activity to its broader vision of participating in future-facing digital infrastructure and Web3-related initiatives.

Pharmaceutical Distribution and European Operations

Through Phatebo GmbH, Flora has described itself as a prominent distributor of pharmaceutical products in the European Union and as a holder of a medical cannabis licence in Germany. Company communications reference a parallel import business in Germany that is intended to provide European consumers with pharmaceuticals at competitive prices, subject to European regulatory frameworks. Flora has also highlighted its interest in German cannabis regulatory developments, including cannabis pilot programs and changes to industrial hemp regulations, and has indicated its intention to submit applications for participation in certain German cannabis pilot programs.

Evolution from Cannabis and Consumer Products

Historically, Flora has described activities in the cannabis and consumer products space, including THC-infused beverages, cannabis-related brands and product development under the Vessel brand. Over time, company communications show a shift toward a digital asset treasury strategy and decentralized AI exposure, while still referencing its role as a pharmaceutical distributor and its licensing position in Germany. The company’s more recent disclosures emphasize its identity as a decentralized AI treasury company and its planned rebranding to ZeroStack, while also noting its continuing pharmaceutical distribution business.